256 related articles for article (PubMed ID: 15389205)
21. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
[TBL] [Abstract][Full Text] [Related]
22. Lentigo maligna successfully treated with imiquimod.
du Plessis PJ
S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
[No Abstract] [Full Text] [Related]
23. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
24. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Woodmansee CS; McCall MW
Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
[No Abstract] [Full Text] [Related]
25. Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients.
Van Meurs T; Van Doorn R; Kirtschig G
Dermatol Surg; 2010 Jun; 36(6):853-8. PubMed ID: 20618370
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens.
Flores S; Luby NJ; Bowen GM
JAMA Dermatol; 2018 Apr; 154(4):482-484. PubMed ID: 29453870
[TBL] [Abstract][Full Text] [Related]
27. Topical imiquimod immunotherapy in the management of lentigo maligna.
Powell AM; Russell-Jones R; Barlow RJ
Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
[TBL] [Abstract][Full Text] [Related]
28. Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.
Gautschi M; Oberholzer PA; Baumgartner M; Gadaldi K; Yawalkar N; Hunger RE
J Am Acad Dermatol; 2016 Jan; 74(1):81-87.e1. PubMed ID: 26601565
[TBL] [Abstract][Full Text] [Related]
29. Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production.
Martires KJ; Capaldi L; Pattee SF; Maloney ME; Bordeaux JS
Arch Dermatol; 2010 Sep; 146(9):1047-8. PubMed ID: 20855714
[No Abstract] [Full Text] [Related]
30. Topical imiquimod therapy for lentigo maligna.
Mahoney MH; Joseph MG; Temple C
Ann Plast Surg; 2008 Oct; 61(4):419-24. PubMed ID: 18812714
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials.
Astorino S; Astorre P; Pasquini P; Di Nunno D; Pellegrini F; Paolino G
Dermatol Ther; 2019 Jan; 32(1):e12757. PubMed ID: 30285299
[No Abstract] [Full Text] [Related]
32. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
[TBL] [Abstract][Full Text] [Related]
33. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
34. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
35. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Fisher GH; Lang PG
Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
[No Abstract] [Full Text] [Related]
36. Topical 5% imiquimod in the treatment of lentigo maligna.
Wong JG; Toole JW; Demers AA; Musto G; Wiseman MC
J Cutan Med Surg; 2012; 16(4):245-9. PubMed ID: 22784516
[TBL] [Abstract][Full Text] [Related]
37. Image in clinical medicine. Lentigo maligna.
Noel B; Kunzle N
N Engl J Med; 2005 Nov; 353(20):2176. PubMed ID: 16291987
[No Abstract] [Full Text] [Related]
38. A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
Mora AN; Karia PS; Nguyen BM
J Am Acad Dermatol; 2015 Aug; 73(2):205-12. PubMed ID: 26088690
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
Powell AM; Robson AM; Russell-Jones R; Barlow RJ
Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of Amelanotic Lentigo Maligna by Using In vivo Reflectance Confocal Microscopy.
Alani A; Ramsay B; Ahmad K
Acta Derm Venereol; 2016 Mar; 96(3):406-7. PubMed ID: 26524567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
